Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
541
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Patients with vulvar lichen sclerosus prioritize education on disease etiology, triggers and treatment

Emily A. Parksa Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaView further author information
,
Mallory L. Zainoa Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6495-8192View further author information
ORCID Icon,
Jessica N. Pixleya Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaORCID Iconhttps://orcid.org/0000-0001-9049-1808View further author information
ORCID Icon,
Vani Mangalam Subramanianb Sensal Health, Chapel Hill, North CarolinaView further author information
,
Deepak Sirdeshmukhb Sensal Health, Chapel Hill, North CarolinaView further author information
,
Steven R. Feldmana Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina;c Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina;d Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina;e Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North CarolinaORCID Iconhttps://orcid.org/0000-0002-0090-6289View further author information
ORCID Icon &
Rita O. Pichardoc Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaView further author information
 show all
Article: 2262632 | Received 19 Sep 2023, Accepted 19 Sep 2023, Published online: 31 Oct 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Patients with vulvar lichen sclerosus prioritize education on disease etiology, triggers and treatment." Journal of Dermatological Treatment, 34(1), pp.

Disclosure statement

Feldman has received research, speaking and/or consulting support from AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Eurofins, Forte, Galderma, Helsinn, Janssen, Leo Pharma, Micreos, Mylan, Novartis, Ono, Ortho Dermatology, Pfizer, Regeneron, Samsung, Sanofi, Sun Pharma, UCB, Verrica, Voluntis, and vTv Therapeutics. He is founder and part owner of Causa Research and holds stock in Sensal Health. Pichardo worked at the advisory board for Novartis. Zaino, Pixley and Parks have no conflicts of interest to disclose.

Additional information

Funding

None.
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.